Medical Care
Global Stroke Diagnostics Market Research Report 2025
- Apr 07, 25
- ID: 167623
- Pages: 98
- Figures: 99
- Views: 29
The global market for Stroke Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Stroke Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stroke Diagnostics.
The Stroke Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stroke Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stroke Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories Ltd.
Medtronic(Covidien)
General Electric Company(GE Healthcare)
Hitachi, Ltd.
Johnson & Johnson
Penumbra, Inc.
Koninklijke Philips N.V.
Siemens(Siemens International GmbH)
Stryker Corporation (Concentric Medical, Inc.)
Canon Medical Systems Corporation
Nihon Kohden Corporation
Sense Neuro Diagnostics
Forest Devices
Brainomix
Jan Medical
RapidAI
Viz.ai
Segment by Type
Software
Hardware
Segment by Application
Ischemic Stroke
Hemorrhagic Stroke
Transient Ischemic Attack
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stroke Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Stroke Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stroke Diagnostics.
The Stroke Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stroke Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stroke Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories Ltd.
Medtronic(Covidien)
General Electric Company(GE Healthcare)
Hitachi, Ltd.
Johnson & Johnson
Penumbra, Inc.
Koninklijke Philips N.V.
Siemens(Siemens International GmbH)
Stryker Corporation (Concentric Medical, Inc.)
Canon Medical Systems Corporation
Nihon Kohden Corporation
Sense Neuro Diagnostics
Forest Devices
Brainomix
Jan Medical
RapidAI
Viz.ai
Segment by Type
Software
Hardware
Segment by Application
Ischemic Stroke
Hemorrhagic Stroke
Transient Ischemic Attack
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stroke Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stroke Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Software
1.2.3 Hardware
1.3 Market by Application
1.3.1 Global Stroke Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Ischemic Stroke
1.3.3 Hemorrhagic Stroke
1.3.4 Transient Ischemic Attack
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stroke Diagnostics Market Perspective (2020-2031)
2.2 Global Stroke Diagnostics Growth Trends by Region
2.2.1 Global Stroke Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Stroke Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Stroke Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Stroke Diagnostics Market Dynamics
2.3.1 Stroke Diagnostics Industry Trends
2.3.2 Stroke Diagnostics Market Drivers
2.3.3 Stroke Diagnostics Market Challenges
2.3.4 Stroke Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stroke Diagnostics Players by Revenue
3.1.1 Global Top Stroke Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Stroke Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Stroke Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Stroke Diagnostics Revenue
3.4 Global Stroke Diagnostics Market Concentration Ratio
3.4.1 Global Stroke Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stroke Diagnostics Revenue in 2024
3.5 Global Key Players of Stroke Diagnostics Head office and Area Served
3.6 Global Key Players of Stroke Diagnostics, Product and Application
3.7 Global Key Players of Stroke Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Stroke Diagnostics Breakdown Data by Type
4.1 Global Stroke Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Stroke Diagnostics Forecasted Market Size by Type (2026-2031)
5 Stroke Diagnostics Breakdown Data by Application
5.1 Global Stroke Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Stroke Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Stroke Diagnostics Market Size (2020-2031)
6.2 North America Stroke Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Stroke Diagnostics Market Size by Country (2020-2025)
6.4 North America Stroke Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stroke Diagnostics Market Size (2020-2031)
7.2 Europe Stroke Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Stroke Diagnostics Market Size by Country (2020-2025)
7.4 Europe Stroke Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stroke Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Stroke Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Stroke Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Stroke Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Stroke Diagnostics Market Size (2020-2031)
9.2 Latin America Stroke Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Stroke Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Stroke Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stroke Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Stroke Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Stroke Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Stroke Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories Ltd.
11.1.1 Abbott Laboratories Ltd. Company Details
11.1.2 Abbott Laboratories Ltd. Business Overview
11.1.3 Abbott Laboratories Ltd. Stroke Diagnostics Introduction
11.1.4 Abbott Laboratories Ltd. Revenue in Stroke Diagnostics Business (2020-2025)
11.1.5 Abbott Laboratories Ltd. Recent Development
11.2 Medtronic(Covidien)
11.2.1 Medtronic(Covidien) Company Details
11.2.2 Medtronic(Covidien) Business Overview
11.2.3 Medtronic(Covidien) Stroke Diagnostics Introduction
11.2.4 Medtronic(Covidien) Revenue in Stroke Diagnostics Business (2020-2025)
11.2.5 Medtronic(Covidien) Recent Development
11.3 General Electric Company(GE Healthcare)
11.3.1 General Electric Company(GE Healthcare) Company Details
11.3.2 General Electric Company(GE Healthcare) Business Overview
11.3.3 General Electric Company(GE Healthcare) Stroke Diagnostics Introduction
11.3.4 General Electric Company(GE Healthcare) Revenue in Stroke Diagnostics Business (2020-2025)
11.3.5 General Electric Company(GE Healthcare) Recent Development
11.4 Hitachi, Ltd.
11.4.1 Hitachi, Ltd. Company Details
11.4.2 Hitachi, Ltd. Business Overview
11.4.3 Hitachi, Ltd. Stroke Diagnostics Introduction
11.4.4 Hitachi, Ltd. Revenue in Stroke Diagnostics Business (2020-2025)
11.4.5 Hitachi, Ltd. Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Stroke Diagnostics Introduction
11.5.4 Johnson & Johnson Revenue in Stroke Diagnostics Business (2020-2025)
11.5.5 Johnson & Johnson Recent Development
11.6 Penumbra, Inc.
11.6.1 Penumbra, Inc. Company Details
11.6.2 Penumbra, Inc. Business Overview
11.6.3 Penumbra, Inc. Stroke Diagnostics Introduction
11.6.4 Penumbra, Inc. Revenue in Stroke Diagnostics Business (2020-2025)
11.6.5 Penumbra, Inc. Recent Development
11.7 Koninklijke Philips N.V.
11.7.1 Koninklijke Philips N.V. Company Details
11.7.2 Koninklijke Philips N.V. Business Overview
11.7.3 Koninklijke Philips N.V. Stroke Diagnostics Introduction
11.7.4 Koninklijke Philips N.V. Revenue in Stroke Diagnostics Business (2020-2025)
11.7.5 Koninklijke Philips N.V. Recent Development
11.8 Siemens(Siemens International GmbH)
11.8.1 Siemens(Siemens International GmbH) Company Details
11.8.2 Siemens(Siemens International GmbH) Business Overview
11.8.3 Siemens(Siemens International GmbH) Stroke Diagnostics Introduction
11.8.4 Siemens(Siemens International GmbH) Revenue in Stroke Diagnostics Business (2020-2025)
11.8.5 Siemens(Siemens International GmbH) Recent Development
11.9 Stryker Corporation (Concentric Medical, Inc.)
11.9.1 Stryker Corporation (Concentric Medical, Inc.) Company Details
11.9.2 Stryker Corporation (Concentric Medical, Inc.) Business Overview
11.9.3 Stryker Corporation (Concentric Medical, Inc.) Stroke Diagnostics Introduction
11.9.4 Stryker Corporation (Concentric Medical, Inc.) Revenue in Stroke Diagnostics Business (2020-2025)
11.9.5 Stryker Corporation (Concentric Medical, Inc.) Recent Development
11.10 Canon Medical Systems Corporation
11.10.1 Canon Medical Systems Corporation Company Details
11.10.2 Canon Medical Systems Corporation Business Overview
11.10.3 Canon Medical Systems Corporation Stroke Diagnostics Introduction
11.10.4 Canon Medical Systems Corporation Revenue in Stroke Diagnostics Business (2020-2025)
11.10.5 Canon Medical Systems Corporation Recent Development
11.11 Nihon Kohden Corporation
11.11.1 Nihon Kohden Corporation Company Details
11.11.2 Nihon Kohden Corporation Business Overview
11.11.3 Nihon Kohden Corporation Stroke Diagnostics Introduction
11.11.4 Nihon Kohden Corporation Revenue in Stroke Diagnostics Business (2020-2025)
11.11.5 Nihon Kohden Corporation Recent Development
11.12 Sense Neuro Diagnostics
11.12.1 Sense Neuro Diagnostics Company Details
11.12.2 Sense Neuro Diagnostics Business Overview
11.12.3 Sense Neuro Diagnostics Stroke Diagnostics Introduction
11.12.4 Sense Neuro Diagnostics Revenue in Stroke Diagnostics Business (2020-2025)
11.12.5 Sense Neuro Diagnostics Recent Development
11.13 Forest Devices
11.13.1 Forest Devices Company Details
11.13.2 Forest Devices Business Overview
11.13.3 Forest Devices Stroke Diagnostics Introduction
11.13.4 Forest Devices Revenue in Stroke Diagnostics Business (2020-2025)
11.13.5 Forest Devices Recent Development
11.14 Brainomix
11.14.1 Brainomix Company Details
11.14.2 Brainomix Business Overview
11.14.3 Brainomix Stroke Diagnostics Introduction
11.14.4 Brainomix Revenue in Stroke Diagnostics Business (2020-2025)
11.14.5 Brainomix Recent Development
11.15 Jan Medical
11.15.1 Jan Medical Company Details
11.15.2 Jan Medical Business Overview
11.15.3 Jan Medical Stroke Diagnostics Introduction
11.15.4 Jan Medical Revenue in Stroke Diagnostics Business (2020-2025)
11.15.5 Jan Medical Recent Development
11.16 RapidAI
11.16.1 RapidAI Company Details
11.16.2 RapidAI Business Overview
11.16.3 RapidAI Stroke Diagnostics Introduction
11.16.4 RapidAI Revenue in Stroke Diagnostics Business (2020-2025)
11.16.5 RapidAI Recent Development
11.17 Viz.ai
11.17.1 Viz.ai Company Details
11.17.2 Viz.ai Business Overview
11.17.3 Viz.ai Stroke Diagnostics Introduction
11.17.4 Viz.ai Revenue in Stroke Diagnostics Business (2020-2025)
11.17.5 Viz.ai Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stroke Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Software
1.2.3 Hardware
1.3 Market by Application
1.3.1 Global Stroke Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Ischemic Stroke
1.3.3 Hemorrhagic Stroke
1.3.4 Transient Ischemic Attack
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stroke Diagnostics Market Perspective (2020-2031)
2.2 Global Stroke Diagnostics Growth Trends by Region
2.2.1 Global Stroke Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Stroke Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Stroke Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Stroke Diagnostics Market Dynamics
2.3.1 Stroke Diagnostics Industry Trends
2.3.2 Stroke Diagnostics Market Drivers
2.3.3 Stroke Diagnostics Market Challenges
2.3.4 Stroke Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stroke Diagnostics Players by Revenue
3.1.1 Global Top Stroke Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Stroke Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Stroke Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Stroke Diagnostics Revenue
3.4 Global Stroke Diagnostics Market Concentration Ratio
3.4.1 Global Stroke Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stroke Diagnostics Revenue in 2024
3.5 Global Key Players of Stroke Diagnostics Head office and Area Served
3.6 Global Key Players of Stroke Diagnostics, Product and Application
3.7 Global Key Players of Stroke Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Stroke Diagnostics Breakdown Data by Type
4.1 Global Stroke Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Stroke Diagnostics Forecasted Market Size by Type (2026-2031)
5 Stroke Diagnostics Breakdown Data by Application
5.1 Global Stroke Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Stroke Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Stroke Diagnostics Market Size (2020-2031)
6.2 North America Stroke Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Stroke Diagnostics Market Size by Country (2020-2025)
6.4 North America Stroke Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stroke Diagnostics Market Size (2020-2031)
7.2 Europe Stroke Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Stroke Diagnostics Market Size by Country (2020-2025)
7.4 Europe Stroke Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stroke Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Stroke Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Stroke Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Stroke Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Stroke Diagnostics Market Size (2020-2031)
9.2 Latin America Stroke Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Stroke Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Stroke Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stroke Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Stroke Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Stroke Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Stroke Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories Ltd.
11.1.1 Abbott Laboratories Ltd. Company Details
11.1.2 Abbott Laboratories Ltd. Business Overview
11.1.3 Abbott Laboratories Ltd. Stroke Diagnostics Introduction
11.1.4 Abbott Laboratories Ltd. Revenue in Stroke Diagnostics Business (2020-2025)
11.1.5 Abbott Laboratories Ltd. Recent Development
11.2 Medtronic(Covidien)
11.2.1 Medtronic(Covidien) Company Details
11.2.2 Medtronic(Covidien) Business Overview
11.2.3 Medtronic(Covidien) Stroke Diagnostics Introduction
11.2.4 Medtronic(Covidien) Revenue in Stroke Diagnostics Business (2020-2025)
11.2.5 Medtronic(Covidien) Recent Development
11.3 General Electric Company(GE Healthcare)
11.3.1 General Electric Company(GE Healthcare) Company Details
11.3.2 General Electric Company(GE Healthcare) Business Overview
11.3.3 General Electric Company(GE Healthcare) Stroke Diagnostics Introduction
11.3.4 General Electric Company(GE Healthcare) Revenue in Stroke Diagnostics Business (2020-2025)
11.3.5 General Electric Company(GE Healthcare) Recent Development
11.4 Hitachi, Ltd.
11.4.1 Hitachi, Ltd. Company Details
11.4.2 Hitachi, Ltd. Business Overview
11.4.3 Hitachi, Ltd. Stroke Diagnostics Introduction
11.4.4 Hitachi, Ltd. Revenue in Stroke Diagnostics Business (2020-2025)
11.4.5 Hitachi, Ltd. Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Stroke Diagnostics Introduction
11.5.4 Johnson & Johnson Revenue in Stroke Diagnostics Business (2020-2025)
11.5.5 Johnson & Johnson Recent Development
11.6 Penumbra, Inc.
11.6.1 Penumbra, Inc. Company Details
11.6.2 Penumbra, Inc. Business Overview
11.6.3 Penumbra, Inc. Stroke Diagnostics Introduction
11.6.4 Penumbra, Inc. Revenue in Stroke Diagnostics Business (2020-2025)
11.6.5 Penumbra, Inc. Recent Development
11.7 Koninklijke Philips N.V.
11.7.1 Koninklijke Philips N.V. Company Details
11.7.2 Koninklijke Philips N.V. Business Overview
11.7.3 Koninklijke Philips N.V. Stroke Diagnostics Introduction
11.7.4 Koninklijke Philips N.V. Revenue in Stroke Diagnostics Business (2020-2025)
11.7.5 Koninklijke Philips N.V. Recent Development
11.8 Siemens(Siemens International GmbH)
11.8.1 Siemens(Siemens International GmbH) Company Details
11.8.2 Siemens(Siemens International GmbH) Business Overview
11.8.3 Siemens(Siemens International GmbH) Stroke Diagnostics Introduction
11.8.4 Siemens(Siemens International GmbH) Revenue in Stroke Diagnostics Business (2020-2025)
11.8.5 Siemens(Siemens International GmbH) Recent Development
11.9 Stryker Corporation (Concentric Medical, Inc.)
11.9.1 Stryker Corporation (Concentric Medical, Inc.) Company Details
11.9.2 Stryker Corporation (Concentric Medical, Inc.) Business Overview
11.9.3 Stryker Corporation (Concentric Medical, Inc.) Stroke Diagnostics Introduction
11.9.4 Stryker Corporation (Concentric Medical, Inc.) Revenue in Stroke Diagnostics Business (2020-2025)
11.9.5 Stryker Corporation (Concentric Medical, Inc.) Recent Development
11.10 Canon Medical Systems Corporation
11.10.1 Canon Medical Systems Corporation Company Details
11.10.2 Canon Medical Systems Corporation Business Overview
11.10.3 Canon Medical Systems Corporation Stroke Diagnostics Introduction
11.10.4 Canon Medical Systems Corporation Revenue in Stroke Diagnostics Business (2020-2025)
11.10.5 Canon Medical Systems Corporation Recent Development
11.11 Nihon Kohden Corporation
11.11.1 Nihon Kohden Corporation Company Details
11.11.2 Nihon Kohden Corporation Business Overview
11.11.3 Nihon Kohden Corporation Stroke Diagnostics Introduction
11.11.4 Nihon Kohden Corporation Revenue in Stroke Diagnostics Business (2020-2025)
11.11.5 Nihon Kohden Corporation Recent Development
11.12 Sense Neuro Diagnostics
11.12.1 Sense Neuro Diagnostics Company Details
11.12.2 Sense Neuro Diagnostics Business Overview
11.12.3 Sense Neuro Diagnostics Stroke Diagnostics Introduction
11.12.4 Sense Neuro Diagnostics Revenue in Stroke Diagnostics Business (2020-2025)
11.12.5 Sense Neuro Diagnostics Recent Development
11.13 Forest Devices
11.13.1 Forest Devices Company Details
11.13.2 Forest Devices Business Overview
11.13.3 Forest Devices Stroke Diagnostics Introduction
11.13.4 Forest Devices Revenue in Stroke Diagnostics Business (2020-2025)
11.13.5 Forest Devices Recent Development
11.14 Brainomix
11.14.1 Brainomix Company Details
11.14.2 Brainomix Business Overview
11.14.3 Brainomix Stroke Diagnostics Introduction
11.14.4 Brainomix Revenue in Stroke Diagnostics Business (2020-2025)
11.14.5 Brainomix Recent Development
11.15 Jan Medical
11.15.1 Jan Medical Company Details
11.15.2 Jan Medical Business Overview
11.15.3 Jan Medical Stroke Diagnostics Introduction
11.15.4 Jan Medical Revenue in Stroke Diagnostics Business (2020-2025)
11.15.5 Jan Medical Recent Development
11.16 RapidAI
11.16.1 RapidAI Company Details
11.16.2 RapidAI Business Overview
11.16.3 RapidAI Stroke Diagnostics Introduction
11.16.4 RapidAI Revenue in Stroke Diagnostics Business (2020-2025)
11.16.5 RapidAI Recent Development
11.17 Viz.ai
11.17.1 Viz.ai Company Details
11.17.2 Viz.ai Business Overview
11.17.3 Viz.ai Stroke Diagnostics Introduction
11.17.4 Viz.ai Revenue in Stroke Diagnostics Business (2020-2025)
11.17.5 Viz.ai Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Stroke Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Software
Table 3. Key Players of Hardware
Table 4. Global Stroke Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Stroke Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Stroke Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Stroke Diagnostics Market Share by Region (2020-2025)
Table 8. Global Stroke Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Stroke Diagnostics Market Share by Region (2026-2031)
Table 10. Stroke Diagnostics Market Trends
Table 11. Stroke Diagnostics Market Drivers
Table 12. Stroke Diagnostics Market Challenges
Table 13. Stroke Diagnostics Market Restraints
Table 14. Global Stroke Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Stroke Diagnostics Market Share by Players (2020-2025)
Table 16. Global Top Stroke Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Diagnostics as of 2024)
Table 17. Ranking of Global Top Stroke Diagnostics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Stroke Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Stroke Diagnostics, Headquarters and Area Served
Table 20. Global Key Players of Stroke Diagnostics, Product and Application
Table 21. Global Key Players of Stroke Diagnostics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Stroke Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Stroke Diagnostics Revenue Market Share by Type (2020-2025)
Table 25. Global Stroke Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Stroke Diagnostics Revenue Market Share by Type (2026-2031)
Table 27. Global Stroke Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Stroke Diagnostics Revenue Market Share by Application (2020-2025)
Table 29. Global Stroke Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Stroke Diagnostics Revenue Market Share by Application (2026-2031)
Table 31. North America Stroke Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Stroke Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Stroke Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Stroke Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Stroke Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Stroke Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Stroke Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Stroke Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Stroke Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Stroke Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Stroke Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Stroke Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Stroke Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Stroke Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Stroke Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Abbott Laboratories Ltd. Company Details
Table 47. Abbott Laboratories Ltd. Business Overview
Table 48. Abbott Laboratories Ltd. Stroke Diagnostics Product
Table 49. Abbott Laboratories Ltd. Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 50. Abbott Laboratories Ltd. Recent Development
Table 51. Medtronic(Covidien) Company Details
Table 52. Medtronic(Covidien) Business Overview
Table 53. Medtronic(Covidien) Stroke Diagnostics Product
Table 54. Medtronic(Covidien) Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 55. Medtronic(Covidien) Recent Development
Table 56. General Electric Company(GE Healthcare) Company Details
Table 57. General Electric Company(GE Healthcare) Business Overview
Table 58. General Electric Company(GE Healthcare) Stroke Diagnostics Product
Table 59. General Electric Company(GE Healthcare) Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 60. General Electric Company(GE Healthcare) Recent Development
Table 61. Hitachi, Ltd. Company Details
Table 62. Hitachi, Ltd. Business Overview
Table 63. Hitachi, Ltd. Stroke Diagnostics Product
Table 64. Hitachi, Ltd. Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 65. Hitachi, Ltd. Recent Development
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Stroke Diagnostics Product
Table 69. Johnson & Johnson Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. Penumbra, Inc. Company Details
Table 72. Penumbra, Inc. Business Overview
Table 73. Penumbra, Inc. Stroke Diagnostics Product
Table 74. Penumbra, Inc. Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 75. Penumbra, Inc. Recent Development
Table 76. Koninklijke Philips N.V. Company Details
Table 77. Koninklijke Philips N.V. Business Overview
Table 78. Koninklijke Philips N.V. Stroke Diagnostics Product
Table 79. Koninklijke Philips N.V. Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 80. Koninklijke Philips N.V. Recent Development
Table 81. Siemens(Siemens International GmbH) Company Details
Table 82. Siemens(Siemens International GmbH) Business Overview
Table 83. Siemens(Siemens International GmbH) Stroke Diagnostics Product
Table 84. Siemens(Siemens International GmbH) Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 85. Siemens(Siemens International GmbH) Recent Development
Table 86. Stryker Corporation (Concentric Medical, Inc.) Company Details
Table 87. Stryker Corporation (Concentric Medical, Inc.) Business Overview
Table 88. Stryker Corporation (Concentric Medical, Inc.) Stroke Diagnostics Product
Table 89. Stryker Corporation (Concentric Medical, Inc.) Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 90. Stryker Corporation (Concentric Medical, Inc.) Recent Development
Table 91. Canon Medical Systems Corporation Company Details
Table 92. Canon Medical Systems Corporation Business Overview
Table 93. Canon Medical Systems Corporation Stroke Diagnostics Product
Table 94. Canon Medical Systems Corporation Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 95. Canon Medical Systems Corporation Recent Development
Table 96. Nihon Kohden Corporation Company Details
Table 97. Nihon Kohden Corporation Business Overview
Table 98. Nihon Kohden Corporation Stroke Diagnostics Product
Table 99. Nihon Kohden Corporation Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 100. Nihon Kohden Corporation Recent Development
Table 101. Sense Neuro Diagnostics Company Details
Table 102. Sense Neuro Diagnostics Business Overview
Table 103. Sense Neuro Diagnostics Stroke Diagnostics Product
Table 104. Sense Neuro Diagnostics Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 105. Sense Neuro Diagnostics Recent Development
Table 106. Forest Devices Company Details
Table 107. Forest Devices Business Overview
Table 108. Forest Devices Stroke Diagnostics Product
Table 109. Forest Devices Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 110. Forest Devices Recent Development
Table 111. Brainomix Company Details
Table 112. Brainomix Business Overview
Table 113. Brainomix Stroke Diagnostics Product
Table 114. Brainomix Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 115. Brainomix Recent Development
Table 116. Jan Medical Company Details
Table 117. Jan Medical Business Overview
Table 118. Jan Medical Stroke Diagnostics Product
Table 119. Jan Medical Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 120. Jan Medical Recent Development
Table 121. RapidAI Company Details
Table 122. RapidAI Business Overview
Table 123. RapidAI Stroke Diagnostics Product
Table 124. RapidAI Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 125. RapidAI Recent Development
Table 126. Viz.ai Company Details
Table 127. Viz.ai Business Overview
Table 128. Viz.ai Stroke Diagnostics Product
Table 129. Viz.ai Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 130. Viz.ai Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report
List of Figures
Figure 1. Stroke Diagnostics Picture
Figure 2. Global Stroke Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Stroke Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Software Features
Figure 5. Hardware Features
Figure 6. Global Stroke Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Stroke Diagnostics Market Share by Application: 2024 VS 2031
Figure 8. Ischemic Stroke Case Studies
Figure 9. Hemorrhagic Stroke Case Studies
Figure 10. Transient Ischemic Attack Case Studies
Figure 11. Stroke Diagnostics Report Years Considered
Figure 12. Global Stroke Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Stroke Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Stroke Diagnostics Market Share by Region: 2024 VS 2031
Figure 15. Global Stroke Diagnostics Market Share by Players in 2024
Figure 16. Global Top Stroke Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Diagnostics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Stroke Diagnostics Revenue in 2024
Figure 18. North America Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Stroke Diagnostics Market Share by Country (2020-2031)
Figure 20. United States Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Stroke Diagnostics Market Share by Country (2020-2031)
Figure 24. Germany Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Stroke Diagnostics Market Share by Region (2020-2031)
Figure 32. China Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Stroke Diagnostics Market Share by Country (2020-2031)
Figure 40. Mexico Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Stroke Diagnostics Market Share by Country (2020-2031)
Figure 44. Turkey Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Abbott Laboratories Ltd. Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 48. Medtronic(Covidien) Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 49. General Electric Company(GE Healthcare) Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 50. Hitachi, Ltd. Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 51. Johnson & Johnson Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 52. Penumbra, Inc. Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 53. Koninklijke Philips N.V. Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 54. Siemens(Siemens International GmbH) Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 55. Stryker Corporation (Concentric Medical, Inc.) Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 56. Canon Medical Systems Corporation Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 57. Nihon Kohden Corporation Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 58. Sense Neuro Diagnostics Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 59. Forest Devices Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 60. Brainomix Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 61. Jan Medical Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 62. RapidAI Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 63. Viz.ai Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Stroke Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Software
Table 3. Key Players of Hardware
Table 4. Global Stroke Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Stroke Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Stroke Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Stroke Diagnostics Market Share by Region (2020-2025)
Table 8. Global Stroke Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Stroke Diagnostics Market Share by Region (2026-2031)
Table 10. Stroke Diagnostics Market Trends
Table 11. Stroke Diagnostics Market Drivers
Table 12. Stroke Diagnostics Market Challenges
Table 13. Stroke Diagnostics Market Restraints
Table 14. Global Stroke Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Stroke Diagnostics Market Share by Players (2020-2025)
Table 16. Global Top Stroke Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Diagnostics as of 2024)
Table 17. Ranking of Global Top Stroke Diagnostics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Stroke Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Stroke Diagnostics, Headquarters and Area Served
Table 20. Global Key Players of Stroke Diagnostics, Product and Application
Table 21. Global Key Players of Stroke Diagnostics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Stroke Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Stroke Diagnostics Revenue Market Share by Type (2020-2025)
Table 25. Global Stroke Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Stroke Diagnostics Revenue Market Share by Type (2026-2031)
Table 27. Global Stroke Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Stroke Diagnostics Revenue Market Share by Application (2020-2025)
Table 29. Global Stroke Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Stroke Diagnostics Revenue Market Share by Application (2026-2031)
Table 31. North America Stroke Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Stroke Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Stroke Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Stroke Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Stroke Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Stroke Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Stroke Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Stroke Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Stroke Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Stroke Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Stroke Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Stroke Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Stroke Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Stroke Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Stroke Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Abbott Laboratories Ltd. Company Details
Table 47. Abbott Laboratories Ltd. Business Overview
Table 48. Abbott Laboratories Ltd. Stroke Diagnostics Product
Table 49. Abbott Laboratories Ltd. Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 50. Abbott Laboratories Ltd. Recent Development
Table 51. Medtronic(Covidien) Company Details
Table 52. Medtronic(Covidien) Business Overview
Table 53. Medtronic(Covidien) Stroke Diagnostics Product
Table 54. Medtronic(Covidien) Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 55. Medtronic(Covidien) Recent Development
Table 56. General Electric Company(GE Healthcare) Company Details
Table 57. General Electric Company(GE Healthcare) Business Overview
Table 58. General Electric Company(GE Healthcare) Stroke Diagnostics Product
Table 59. General Electric Company(GE Healthcare) Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 60. General Electric Company(GE Healthcare) Recent Development
Table 61. Hitachi, Ltd. Company Details
Table 62. Hitachi, Ltd. Business Overview
Table 63. Hitachi, Ltd. Stroke Diagnostics Product
Table 64. Hitachi, Ltd. Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 65. Hitachi, Ltd. Recent Development
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Stroke Diagnostics Product
Table 69. Johnson & Johnson Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. Penumbra, Inc. Company Details
Table 72. Penumbra, Inc. Business Overview
Table 73. Penumbra, Inc. Stroke Diagnostics Product
Table 74. Penumbra, Inc. Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 75. Penumbra, Inc. Recent Development
Table 76. Koninklijke Philips N.V. Company Details
Table 77. Koninklijke Philips N.V. Business Overview
Table 78. Koninklijke Philips N.V. Stroke Diagnostics Product
Table 79. Koninklijke Philips N.V. Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 80. Koninklijke Philips N.V. Recent Development
Table 81. Siemens(Siemens International GmbH) Company Details
Table 82. Siemens(Siemens International GmbH) Business Overview
Table 83. Siemens(Siemens International GmbH) Stroke Diagnostics Product
Table 84. Siemens(Siemens International GmbH) Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 85. Siemens(Siemens International GmbH) Recent Development
Table 86. Stryker Corporation (Concentric Medical, Inc.) Company Details
Table 87. Stryker Corporation (Concentric Medical, Inc.) Business Overview
Table 88. Stryker Corporation (Concentric Medical, Inc.) Stroke Diagnostics Product
Table 89. Stryker Corporation (Concentric Medical, Inc.) Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 90. Stryker Corporation (Concentric Medical, Inc.) Recent Development
Table 91. Canon Medical Systems Corporation Company Details
Table 92. Canon Medical Systems Corporation Business Overview
Table 93. Canon Medical Systems Corporation Stroke Diagnostics Product
Table 94. Canon Medical Systems Corporation Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 95. Canon Medical Systems Corporation Recent Development
Table 96. Nihon Kohden Corporation Company Details
Table 97. Nihon Kohden Corporation Business Overview
Table 98. Nihon Kohden Corporation Stroke Diagnostics Product
Table 99. Nihon Kohden Corporation Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 100. Nihon Kohden Corporation Recent Development
Table 101. Sense Neuro Diagnostics Company Details
Table 102. Sense Neuro Diagnostics Business Overview
Table 103. Sense Neuro Diagnostics Stroke Diagnostics Product
Table 104. Sense Neuro Diagnostics Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 105. Sense Neuro Diagnostics Recent Development
Table 106. Forest Devices Company Details
Table 107. Forest Devices Business Overview
Table 108. Forest Devices Stroke Diagnostics Product
Table 109. Forest Devices Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 110. Forest Devices Recent Development
Table 111. Brainomix Company Details
Table 112. Brainomix Business Overview
Table 113. Brainomix Stroke Diagnostics Product
Table 114. Brainomix Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 115. Brainomix Recent Development
Table 116. Jan Medical Company Details
Table 117. Jan Medical Business Overview
Table 118. Jan Medical Stroke Diagnostics Product
Table 119. Jan Medical Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 120. Jan Medical Recent Development
Table 121. RapidAI Company Details
Table 122. RapidAI Business Overview
Table 123. RapidAI Stroke Diagnostics Product
Table 124. RapidAI Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 125. RapidAI Recent Development
Table 126. Viz.ai Company Details
Table 127. Viz.ai Business Overview
Table 128. Viz.ai Stroke Diagnostics Product
Table 129. Viz.ai Revenue in Stroke Diagnostics Business (2020-2025) & (US$ Million)
Table 130. Viz.ai Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report
List of Figures
Figure 1. Stroke Diagnostics Picture
Figure 2. Global Stroke Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Stroke Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Software Features
Figure 5. Hardware Features
Figure 6. Global Stroke Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Stroke Diagnostics Market Share by Application: 2024 VS 2031
Figure 8. Ischemic Stroke Case Studies
Figure 9. Hemorrhagic Stroke Case Studies
Figure 10. Transient Ischemic Attack Case Studies
Figure 11. Stroke Diagnostics Report Years Considered
Figure 12. Global Stroke Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Stroke Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Stroke Diagnostics Market Share by Region: 2024 VS 2031
Figure 15. Global Stroke Diagnostics Market Share by Players in 2024
Figure 16. Global Top Stroke Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Diagnostics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Stroke Diagnostics Revenue in 2024
Figure 18. North America Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Stroke Diagnostics Market Share by Country (2020-2031)
Figure 20. United States Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Stroke Diagnostics Market Share by Country (2020-2031)
Figure 24. Germany Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Stroke Diagnostics Market Share by Region (2020-2031)
Figure 32. China Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Stroke Diagnostics Market Share by Country (2020-2031)
Figure 40. Mexico Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Stroke Diagnostics Market Share by Country (2020-2031)
Figure 44. Turkey Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Stroke Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Abbott Laboratories Ltd. Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 48. Medtronic(Covidien) Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 49. General Electric Company(GE Healthcare) Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 50. Hitachi, Ltd. Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 51. Johnson & Johnson Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 52. Penumbra, Inc. Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 53. Koninklijke Philips N.V. Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 54. Siemens(Siemens International GmbH) Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 55. Stryker Corporation (Concentric Medical, Inc.) Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 56. Canon Medical Systems Corporation Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 57. Nihon Kohden Corporation Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 58. Sense Neuro Diagnostics Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 59. Forest Devices Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 60. Brainomix Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 61. Jan Medical Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 62. RapidAI Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 63. Viz.ai Revenue Growth Rate in Stroke Diagnostics Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232